Cargando…
Restless legs syndrome: differential diagnosis and management with rotigotine
RLS is a common sleep disorder with distinctive clinical features. The prevalence of RLS in Caucasians and North Americans ranges from 5% to 10%. However, only some of these subjects (almost the 3% of the general population) report being affected by a frequent and severe form of the sleep disorder....
Autores principales: | Merlino, Giovanni, Serafini, Anna, Robiony, Francesca, Valente, Mariarosaria, Gigli, Gian Luigi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695234/ https://www.ncbi.nlm.nih.gov/pubmed/19557102 |
Ejemplares similares
-
Ropinirole for the treatment of restless legs syndrome
por: Kushida, Clete A
Publicado: (2006) -
Gabapentin enacarbil – clinical efficacy in restless legs syndrome
por: Agarwal, Pinky, et al.
Publicado: (2010) -
Rotigotine transdermal system: a short review
por: Bunten, Sabine, et al.
Publicado: (2006) -
Transdermal rotigotine for the perioperative management of restless legs syndrome
por: Högl, Birgit, et al.
Publicado: (2012) -
Pramipexole: new use for an old drug – the potential use of pramipexole in the treatment of restless legs syndrome
por: Benbir, Gulcin, et al.
Publicado: (2006)